Hong-liang LIU, Ji-li YUAN, Jing-bo XUE, 等. Chinese Medicine Treatment of Refractory Ascites with Pleural Effusion Caused by Alcoholic Liver Disease: A Case Report[J]. Chinese Journal of Integrative Medicine, 2021,27(3):225-228.
Hong-liang LIU, Ji-li YUAN, Jing-bo XUE, et al. Chinese Medicine Treatment of Refractory Ascites with Pleural Effusion Caused by Alcoholic Liver Disease: A Case Report[J]. Chinese Journal of Integrative Medicine, 2021,27(3):225-228.
Hong-liang LIU, Ji-li YUAN, Jing-bo XUE, 等. Chinese Medicine Treatment of Refractory Ascites with Pleural Effusion Caused by Alcoholic Liver Disease: A Case Report[J]. Chinese Journal of Integrative Medicine, 2021,27(3):225-228. DOI: 10.1007/s11655-020-3253-x.
Hong-liang LIU, Ji-li YUAN, Jing-bo XUE, et al. Chinese Medicine Treatment of Refractory Ascites with Pleural Effusion Caused by Alcoholic Liver Disease: A Case Report[J]. Chinese Journal of Integrative Medicine, 2021,27(3):225-228. DOI: 10.1007/s11655-020-3253-x.
Chinese Medicine Treatment of Refractory Ascites with Pleural Effusion Caused by Alcoholic Liver Disease: A Case Report
摘要
Abstract
关键词
Keywords
references
GBD 2015 Risk Factors Collaborators Global, regional, and national comparative risk assessment of 79 behavioral, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016;388:1659-1724.
Singal AK, Bataller R, Ahn J, Kamath PS, Shah VH.ACG Clinical Guideline: Alcoholic Liver Disease. Am J Gastroenterol 2018:1-19.
Jürgen R, Gmel GE, Gmel G, Hasan OSM, Imtiaz S, Popova S, et al. The relationship between different dimensions of alcohol use and the burden of disease—an update. Addiction 2017:112:968-1001.
Yoon YH, Chen CM, Yi HY. Liver cirrhosis mortality in the United States: national, state, and regional trends, 2000–2011. Surveillance Report 2014:1-63.
Morgan TR, Mandayam S, Jamal MM. Alcohol and hepatocellular carcinoma. Gastroenterology 2004:127:87-96.
Saruta T, Ogihara T, Saito I, Rakugi H, Shimamoto K, Matsuoka H, et al. Comparison of olmesartan combined with a calcium channel blocker or a diuretic in elderly hypertensive patients (COLM Study): safety and tolerability.Hypertens Res 2015;38:132-136.
Runyon BA, AASLD. Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis. Hepatology 2013;57:1651-1653.
European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol 2010;53: 397-417.
Tang JL, Liu BY, Ma KW. Traditional Chinese medicine.Lancet 2008;372:1938-1940.